// App-Quantinova.ai

AB1119 (2022) : GLUCOCORTICOIDS’ TREATMENT IMPAIRS THE MEDIUM-TERM IMMUNOGENIC RESPONSE TO SARS-CoV-2 mRNA VACCINES IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS.

Researchers

Presenter

  • S. Garcia-Cirera

Principal Investigators

  • J. Calvet

  • A. Berenguer-Llergo

  • E. Pradenas

  • M. Llop Vilaltella

  • C. Galisteo

  • J. Blanco

  • J. Gratacos Masmitj

Medical Centers

  • ParcTaulí Hospital Universitari. Institutd’Investigació i Innovació ParcTaulí, Rheumatology, Sabadell, Spain

  • ParcTaulí Hospital Universitari. Institutd’Investigació i Innovació ParcTaulí, Rheumatology, Sabadell, Spain

  • IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), IrsiCaixa AIDS Research Institute, Badalona, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Glucocorticoid

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved